Cognition Life Science Selects Smart Science Laboratories for Production

Smart Science Laboratories is an FDA/GMP approved manufacturer in Tampa

Jan 18, 2016, 08:35 ET from Cognition Life Science, Inc.

TAMPA, Fla., Jan. 18, 2016 /PRNewswire/ -- Cognition Life Science, Inc. (CLS), announced today that it has selected Smart Science Laboratories Inc. as an FDA/ GMP manufacturer for the production of its product for Sleep Disorders. The formulation comes from the acquisition of intellectual property from Dr. Chuanhai Cao, who is a noted researcher at the College of Medicine Neurology and Assistant Professor of Cop. Department of Pharmaceutical Science at USF/Byrd Institute in Tampa, Florida.  The formulation is non-narcotic.

The company hopes to complete stability testing and a full test run by the 2nd quarter of this year with product introduction to the market in the 3rd quarter.

Dr. Chuanhai Cao is one of the first scientists in the world to determine that Marijuana Compounds along with other therapeutic compounds can make a significant difference in sleep disorders like insomnia, Shift Work Sleep Disorder (SWSD), dyssomnia and Circadian Rhythm Sleep Disorder (CRSD).

Sleep disorder affects tens of millions of people.   Sales of both Rx and OTC products are in excess of $20 billion a year. 

About USF/BYRD Institute - The USF/Byrd Institute is dedicated to the prevention, diagnosis, treatment and care of Alzheimer's disease and related disorders.  USF/Byrd have a national and international reputation for excellent research and patient care.

About Dr. Chuanhai Cao – Dr. Cao received his PhD in medical biology at Tianjin China.  He is a prolific inventor and has published many peer reviewed articles.  Dr. Cao has been quoted by the Huffington Post and Fox News.  

About Cognition Life Science, Inc. – Cognition Life Science, Inc. is a privately held new pharmaceutical company which was formed to explore, acquire and develop proprietary formulations to treat neurodegenerative diseases, sleep disorder, mental acuity and pain management.  The company establishes relationships with researchers and accredited laboratories/institutions and explores new ways to deliver existing generic compounds as well as combining natural ingredients which have been shown to be safe and effective.  Certain formulations include THC. 

For more information, contact:

Email 
1302 19th Street, suite 200.  Tampa, Florida 33605 
813 - 563 0544 
Rene de Wit, on behalf of the board.

SOURCE Cognition Life Science, Inc.